Showing results (1441-1450 of 26,316) with videos related to
Sort By:
Pageof 2,632
Bioorganic & Medicinal Chemistry Letters|September 26, 2006
Toward a rational design of selective multi-trypanosomatid inhibitors: a computational docking studyL Michel Espinoza-Fonseca, José G Trujillo-FerraraBioorganic & Medicinal Chemistry Letters|September 26, 2006
Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutationsIgor Nudelman, Annie Rebibo-Sabbah, Dalia Shallom-Shezifi, et al.Bioorganic & Medicinal Chemistry Letters|September 26, 2006
Study on synthesis and biological activity of a galactosylated piperazinyl porphyrinHe-Ping LiBioorganic & Medicinal Chemistry Letters|September 26, 2006
Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitorsChrista E Müller, Jamshed Iqbal, Younis Baqi, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Synthesis and biological evaluation of new biphalin analogues with non-hydrazine linkersAdriano Mollica, Peg Davis, Shou-Wu Ma, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acidJeffrey A Pfefferkorn, Meredith L Greene, Richard A Nugent, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Antiproliferative activity in HL60 cells by tetrasubstituted pyrroles: a structure-activity relationship studyJosé M Padrón, David Tejedor, Alicia Santos-Expósito, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
4-Alkyl and 4,4'-dialkyl 1,2-bis(4-chlorophenyl)pyrazolidine-3,5-dione derivatives as new inhibitors of bacterial cell wall biosynthesisKristina M K Kutterer, Jamie M Davis, Guy Singh, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated miceJoseph Pontillo, Joseph A Tran, Stacy Markison, et al.Bioorganic & Medicinal Chemistry Letters|May 3, 2005
3,3-Bisaryloxindoles as mineralocorticoid receptor antagonistsDavid A Neel, Matthew L Brown, Peter A Lander, et al.Pageof 2,632